期刊
CHEMBIOCHEM
卷 17, 期 9, 页码 836-842出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cbic.201500573
关键词
catalase; hydroxyl radical; photodynamic therapy; radical ions; singlet oxygen; superoxide ion
资金
- Portuguese Science Foundation [PEst-OE/QUI/UI0313/2014, PTDC/QUI-QUI/120182/2010]
- FCT [SFRH/BPD/93562/2013]
- National Science Center (NCN, Poland) [2013/11/D/ST5/02995]
- [QREN/5356]
- Fundação para a Ciência e a Tecnologia [PTDC/QUI-QUI/120182/2010] Funding Source: FCT
Photodynamic therapy (PDT) uses light, photosensitizer molecules and oxygen to generate reactive oxygen species (ROS) that kill cancer cells. Redaporfin, a new photosensitizer in clinical trials, generates both singlet oxygen and superoxide ions. We report the potentiation of redaporfin-PDT in combination with ascorbate and with the inhibition of antioxidant enzymes in A549 (human lung adenocarcinoma) and CT26 (mouse colon adenocarcinoma) cells. The addition of ascorbate and the inhibition of superoxide dismutase (SOD) strongly increased the phototoxicity of redaporfin towards A549 cells but not towards CT26 cells. The inhibition of catalase and the depletion of the glutathione pool also potentiate redaporfin-PDT towards A549 cells. The lower SOD activity of A549 cells might explain this difference. SOD activity levels may be explored to increase the selectivity and efficacy of PDT with photosensitizers that generate radical species.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据